Stocks · Health care · Biological Products, (No Diagnostic Substances)

Surrozen, Inc.

SRZN Clue Score17
United States Fiscal year ends December CIK 0001824893 Results filed 20 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Tim Kutzkey
20 Oct 2026
Director
Exercised, kept indirect
517,241
$11.60
$6.00M
Tim Kutzkey
20 Oct 2026
Director
Exercised, kept indirect
548,653
$11.60
$6.36M
Tim Kutzkey
20 Oct 2026
Director
Exercised, kept indirect
485,830
$11.60
$5.64M
Column Group III Gp, LP
20 Oct 2026
10% owner
Exercised, kept indirect
517,241
$11.60
$6.00M
Column Group III Gp, LP
20 Oct 2026
10% owner
Exercised, kept indirect
548,653
$11.60
$6.36M
Column Group III Gp, LP
20 Oct 2026
10% owner
Exercised, kept indirect
485,830
$11.60
$5.64M

What was left out

Form 4 filings counted 144
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 17
Shares from compensation/vesting 21,439,126
Sales filed before the plan box existed 4
History held since 25 Nov 2020